Type 2 diabetes in Vietnam: a cross-sectional, prevalence-based cost-of-illness study

Nguyen Tu Dang Le, Luyen Dinh Pham, Trung Quang Vo Department of Pharmacy Administration, Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam Background: According to the International Diabetes Federation, total global health care expenditures for...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Le NTD, Dinh Pham L, Quang Vo T
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2017
Materias:	cost-of-illness diabetes mellitus hospital Vietnam. Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/3a7b31b397074b3e95e3e0a94b24c657
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:3a7b31b397074b3e95e3e0a94b24c657
record_format	dspace
spelling	oai:doaj.org-article:3a7b31b397074b3e95e3e0a94b24c6572021-12-02T01:22:17ZType 2 diabetes in Vietnam: a cross-sectional, prevalence-based cost-of-illness study1178-7007https://doaj.org/article/3a7b31b397074b3e95e3e0a94b24c6572017-08-01T00:00:00Zhttps://www.dovepress.com/type-2-diabetes-in-vietnam-a-cross-sectional-prevalence-based-cost-of--peer-reviewed-article-DMSOhttps://doaj.org/toc/1178-7007Nguyen Tu Dang Le, Luyen Dinh Pham, Trung Quang Vo Department of Pharmacy Administration, Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam Background: According to the International Diabetes Federation, total global health care expenditures for diabetes tripled between 2003 and 2013 because of increases in the number of people with diabetes as well as in the average expenditures per patient. This study aims to provide accurate and timely information about the economic impacts of type 2 diabetes mellitus (T2DM) in Vietnam. Method: The cost-of-illness estimates followed a prospective, prevalence-based approach from the societal perspective of T2DM with 392 selected diabetic patients who received treatment from a public hospital in Ho Chi Minh City, Vietnam, during the 2016 fiscal year. Results: In this study, the annual cost per patient estimate was US $246.10 (95% CI 228.3, 267.2) for 392 patients, which accounted for about 12% (95% CI 11, 13) of the gross domestic product per capita in 2017. That includes US $127.30, US $34.40 and US $84.40 for direct medical costs, direct nonmedical expenditures, and indirect costs, respectively. The cost of pharmaceuticals accounted for the bulk of total expenditures in our study (27.5% of total costs and 53.2% of direct medical costs). A bootstrap analysis showed that female patients had a higher cost of treatment than men at US $48.90 (95% CI 3.1, 95.0); those who received insulin and oral antidiabetics (OAD) also had a statistically significant higher cost of treatment compared to those receiving OAD, US $445.90 (95% CI 181.2, 690.6). The Gradient Boosting Regression (Ensemble method) and Lasso Regression (Generalized Linear Models) were determined to be the best models to predict the cost of T2DM (R2=65.3, mean square error [MSE]=0.94; and R2=64.75, MSE=0.96, respectively). Conclusion: The findings of this study serve as a reference for policy decision making in diabetes management as well as adjustment of costs for patients in order to reduce the economic impact of the disease. Keywords: cost-of-illness, diabetes mellitus, hospital, VietnamLe NTDDinh Pham LQuang Vo TDove Medical Pressarticlecost-of-illnessdiabetes mellitushospitalVietnam.Specialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 10, Pp 363-374 (2017)
institution	DOAJ
collection	DOAJ
language	EN
topic	cost-of-illness diabetes mellitus hospital Vietnam. Specialties of internal medicine RC581-951
spellingShingle	cost-of-illness diabetes mellitus hospital Vietnam. Specialties of internal medicine RC581-951 Le NTD Dinh Pham L Quang Vo T Type 2 diabetes in Vietnam: a cross-sectional, prevalence-based cost-of-illness study
description	Nguyen Tu Dang Le, Luyen Dinh Pham, Trung Quang Vo Department of Pharmacy Administration, Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam Background: According to the International Diabetes Federation, total global health care expenditures for diabetes tripled between 2003 and 2013 because of increases in the number of people with diabetes as well as in the average expenditures per patient. This study aims to provide accurate and timely information about the economic impacts of type 2 diabetes mellitus (T2DM) in Vietnam. Method: The cost-of-illness estimates followed a prospective, prevalence-based approach from the societal perspective of T2DM with 392 selected diabetic patients who received treatment from a public hospital in Ho Chi Minh City, Vietnam, during the 2016 fiscal year. Results: In this study, the annual cost per patient estimate was US $246.10 (95% CI 228.3, 267.2) for 392 patients, which accounted for about 12% (95% CI 11, 13) of the gross domestic product per capita in 2017. That includes US $127.30, US $34.40 and US $84.40 for direct medical costs, direct nonmedical expenditures, and indirect costs, respectively. The cost of pharmaceuticals accounted for the bulk of total expenditures in our study (27.5% of total costs and 53.2% of direct medical costs). A bootstrap analysis showed that female patients had a higher cost of treatment than men at US $48.90 (95% CI 3.1, 95.0); those who received insulin and oral antidiabetics (OAD) also had a statistically significant higher cost of treatment compared to those receiving OAD, US $445.90 (95% CI 181.2, 690.6). The Gradient Boosting Regression (Ensemble method) and Lasso Regression (Generalized Linear Models) were determined to be the best models to predict the cost of T2DM (R2=65.3, mean square error [MSE]=0.94; and R2=64.75, MSE=0.96, respectively). Conclusion: The findings of this study serve as a reference for policy decision making in diabetes management as well as adjustment of costs for patients in order to reduce the economic impact of the disease. Keywords: cost-of-illness, diabetes mellitus, hospital, Vietnam
format	article
author	Le NTD Dinh Pham L Quang Vo T
author_facet	Le NTD Dinh Pham L Quang Vo T
author_sort	Le NTD
title	Type 2 diabetes in Vietnam: a cross-sectional, prevalence-based cost-of-illness study
title_short	Type 2 diabetes in Vietnam: a cross-sectional, prevalence-based cost-of-illness study
title_full	Type 2 diabetes in Vietnam: a cross-sectional, prevalence-based cost-of-illness study
title_fullStr	Type 2 diabetes in Vietnam: a cross-sectional, prevalence-based cost-of-illness study
title_full_unstemmed	Type 2 diabetes in Vietnam: a cross-sectional, prevalence-based cost-of-illness study
title_sort	type 2 diabetes in vietnam: a cross-sectional, prevalence-based cost-of-illness study
publisher	Dove Medical Press
publishDate	2017
url	https://doaj.org/article/3a7b31b397074b3e95e3e0a94b24c657
work_keys_str_mv	AT lentd type2diabetesinvietnamacrosssectionalprevalencebasedcostofillnessstudy AT dinhphaml type2diabetesinvietnamacrosssectionalprevalencebasedcostofillnessstudy AT quangvot type2diabetesinvietnamacrosssectionalprevalencebasedcostofillnessstudy
_version_	1718403132723036160

Type 2 diabetes in Vietnam: a cross-sectional, prevalence-based cost-of-illness study

Ejemplares similares